Nadiia Wyttenbach is a healthcare investor with a dual profile in Life Sciences and Investing with over 15 years of combined experience.

In 2009, she started her career in the fast-growing bioprocessing industry. She worked on advanced issues of viral filtration at Sartorius, one of global leader in bioprocessing.

After obtaining a PhD in Molecular Health from ETH in Zürich, she worked in Investment Banking, Private and Listed Equity.

Her investment experience ranges from large, publicly traded firms like IQVIA to small, specialized suppliers, medical technologies and tools companies. Subsector-wise, she has invested across the healthcare continuum, from Pharma and its supply chain to HealthTech and Digital.

Clinical trial expert with 12 years of international experience in both CRO and Sponsor roles, spanning from feasibility to trial reporting across Phase I-IV studies. Highly adept at supervising cross-functional teams in dynamic and fast-paced environments. Recognized as a decisive and trusted team member with an analytical and proactive approach, specializing in various therapeutic areas, including oncology and rare diseases.

Jade Sternberg is a Senior Manager and Digital Health Lead at digitalswitzerland. Passionate about healthcare, technologies and digitalisation, she bridges the gaps between different stakeholder groups in the ecosystem to increase collaboration and innovation. She holds a Bachelor and Master in Bioengineering from EPFL.

Martina holds a Master's in Pharmaceutical Science from Karl-Franzens-University Graz, Austria. Her certifications include Lean Six Sigma Green Belt, St. Gallen Management Institute Business Strategy, and the London Business School programs re. Accelerated Development as well as the Innovation Through Design Thinking.

Over her 25-year career, she's taken on multifaceted roles at Fresenius Kabi, Roche, and MSD, spanning divisions across Research, Manufacturing, Commercial and Global Support Functions. She developed drug products to market and pioneered a novel single-use auto-injection device platform for sterile dosage forms. Beyond product development, Martina has been leading business process streamlining, strategic development, and organizational integration. Her achievements include establishing the global MSD Innovation and Development Hub in Zurich, founding the global MSD Center of Excellence for Comparator Blinding, innovating an early phase biologics supply chain, amplifying Enterprise Strategy Office projects as a Design Thinking Facilitator and enhancing the Global Market Access forecasting methodology. Currently she is creating innovative solutions for clinical supply operations, clinical sites, and leading digitalization as well as people innovation endeavors; she is leading the MSD Digital Display Labeling (DDL) project as well as co-leading the cross-industry DDL Community of Practice.

Brian joined, the then WestRock, in 2018 as Vice President Global Adherence & Clinicals - the business unit focused on providing Adherence focused, patient centric and Child Resistant Senior Friendly (CR-SF) packaging & service solutions to the Pharmaceutical, Biotech & Clinical Trial industries.

Having majored in marketing, business studies and finance Brians key expertise has been developing packaging solutions supplied to these key markets. Holding a wide range of increasingly elevated positions within companies such as Cardinal Health, Catalent and across several other packaging entities, Brian has gained invaluable insights and a thorough understanding of the demanding requirements, operating systems and ethos of the various market sectors that Smurfit Westrock support today.

Within the last number of years Brian's focus, together with his globally based team, has been to strategically develop a bespoke, best in class global supply infrastructure within the Smurfit Westrock specialized field of Adherence, Clinical Trial and SMART digital & electronic platforms. These cutting-edge solutions encompass electronically enhanced SMART measure and monitor packaging solutions, such as Cere®Pak, together with developing the vision and capabilities of Cere®Screen Digital Display Labels within the Clinical Trial Supplies arena..

Josué holds MD from the University of Yaoundé 1, Cameroon and worked (1997-2000) as general practitioner in the University Hospital of Yaoundé. He then completed a MSc in molecular biology at the Free University of Brussels (Vrije Universiteit Brussel), followed by a diabetes cell therapy-focused PhD training and Postdoctoral fellowship at the same university. In 2015, Josué joined the Phase 1 field as Clinical Research Physician in a CRO and started a postgraduate training in Pharmaceutical Medicine, before moving two years later to Pfizer Clinical Research Unit in the role of Principal Investigator. In his current role of Clinical Operations Director, Josué supervises the teams of Investigators, Projects Managers and Regulatory Staff. He is responsible for several innovative projects aiming at improving clinical trial participant’s experience and PCRU deliveries while maintaining full compliance to GCP, national and international regulations. This includes being Subject Matter Expert for electronic consent and for Decentralized Clinical Trial modalities.

Beyza Karakoy is an Analyst in GlobalData’s Strategic Intelligence team, having joined in September 2021. She authors and manages a portfolio of reports, contributing to the analysis of technologies across various sectors, notably financial services and sport. Her areas of expertise include tech regulation, data privacy, legal tech, and AI. Prior to joining GlobalData, Beyza completed her LLM Master of Laws at the London School of Economics and Political Science.

Jasmin Hellwig graduated from the Applied Institute of Science in Muttenz, Switzerland, 2005 in Chemistry and joined Inovalab AG the same year as Study Director. In her various roles, including Business Development, Deputy of the General Management and Deputy of Test Facility Management, she enjoyed facilitating success by supporting processes, which meet high quality and business need. Since 2010 Jasmin is part of the Global Clinical Supplies department of MSD, former Schering Plough. She started as Project Lead coordinating packaging of clinical supplies and supporting integration projects. In September 2014, Jasmin joined the Comparator Sourcing and Planning group, supporting Clinical Trials by purchasing comparators on time from various sources. Since 2020, she fosters the Relationship Management group.

Besides various hobbies she cultivates, particularly horses and singing, she graduated as MSc in Management from the Lorange Business School, Zurich, Switzerland, in 2015.

Joan D’souza's treatment experience includes oncology, dermatology, pain management, infectious disorders, vaccines, drug-device combinations, neurology, cardiovascular gastroenterology, respiratory, orphan diseases, rare diseases, and diabetes.

Joan currently is active in several ISoP special interest groups, including Risk communication (secretary), Medical devices, Geriatric pharmacovigilance, Vaccination, Medication error, and Ecopharmacovigilance. Joan has actively participated in the Pharmacovigilance and Medical devices special interest groups of the European Medical Writers Association. She has frequently written for the ISoP Drug Safety Journal and the European Medical Writers Association Journal. She is also a member of PIPA, UK and RQA, UK. She was also the past-president of ISOP Switzerland and Austria Chapter. She is currently pursuing a Masters in Pharmacovigilance and Pharmacoepidemiology at Eu2P and preparing for her PhD in drug- device combination regulations at the University of Strasbourg.

Joan is a lawyer (JD licensed to practice law in Minnesota, US) and a physician. She earned a Dean's List designation for academic performance after completing a post-baccalaureate clinical research program at the University of Cincinnati in the US. Joan also obtained an advanced diploma in pharmacovigilance with software training. She also runs a non-profit women’s association called VinspireU, that helps women to settle overseas. Joan resides in Switzerland and has a supportive husband and two beautiful girls. During her free time, she likes singing, playing piano, or hiking with her family.

With 7 years of experience in localising paper and electronic COAs, Jonathan today leads translation and questionnaire licensing strategies for YPrime. He develops innovative approaches to ensure quality and accuracy in translated clinical trial materials, focusing on reducing translation burdens and increasing trial diversity. Throughout his career, Jonathan has progressed from Project Manager to Director roles in linguistic validation and quality assurance. He's a trusted SME in localisation best practices, maintaining strong relationships with eCOA providers, pharma sponsors, and copyright holders across the clinical research industry

Over the last 25 years, my career has evolved in various roles and I have held senior positions in the pharma/biotech industry and with international CROs. Comprehensive knowledge and experience in Clinical Operations, experience from First in Human up until late stage. Global experience, understanding the nuances of operating in a diverse environment. Strong leadership skills, with experience in a managerial role. Medical background and advanced IT skills in Trial Management Systems, EDC and e-TMF

My aim is to make the people who report to me feel that they are a valued member of a successful team, doing meaningful work in an environment of trust.

Paul O’Donohoe is Scientific Lead, eCOA and Mobile Health at Medidata Solutions, a clinical software platform provider. He is responsible for developing the company’s scientific expertise for electronic clinical outcome assessments and mobile health, and is responsible for ensuring internal teams, partners and Sponsors are following industry, regulatory and scientific best practices when it comes to integrating technology into clinical trials. He is passionate about developing the field of eCOA and mobile health through research and active involvement in industry consortia, and is currently the Industry Vice-Director of the C-Path ePRO Consortium. Previously, Paul worked as a research psychologist at a child and adolescent mental health clinic based in Dublin, Ireland. He moved into the health consulting field with United BioSource Corporation where he worked across the health outcomes, health economics and health data capture groups. Prior to Medidata, Paul was Director of Health Outcomes at CRF Health, an eCOA provider, where he led their health outcomes team. He has a MSc in Cognitive and Clinical Neuroscience.

With a Master of Science in Biomedical Engineering, Enrico Perfler boasts 20 years of professional experience specializing in medical device technology. His profound knowledge and innovative approach have significantly shaped the landscape of this field.

In 2014, Enrico founded 1MED SA, an innovative international company that provides regulatory support, digital solutions, and comprehensive CRO services to the medical device and pharmaceutical industry, with a particular emphasis on IVD and medical products. Under his leadership, 1MED SA has successfully overseen the development and regulatory approval of over 500 medical devices in Europe, solidifying his status as a prominent figure in the MedTech sector.

Beyond his remarkable entrepreneurial achievements, Enrico serves as a contract professor of "Regulatory Affairs" at the Faculty of Engineering, University of Pavia. His expertise is further highlighted by his participation in the ISO/TC 194 technical committee for the biological evaluation of medical devices, and in national esteemed standardization groups, including UNI and ABHI. This involvement not only showcases his commitment to advancing industry standards but also underlines his influential role in shaping the future of medical device regulation and safety.

Dragan is an IT specialist with a strong entrepreneurial drive. In 2017 he dedicated himself to a mission to help patients get the best possible medical treatment through intelligent software solutions. As a result he co-founded Climedo Health where he took the role of Chief Technology Officer (CTO). At Climedo, Dragan leads dedicated product and tech teams focused on developing top-notch software solutions. These solutions aim to transform post-market #RWE studies by providing better real-time transparency of outcomes and enhancing engagement with healthcare professionals throughout the process.

Jacopo Sgualdino is a Senior Engagement Manager with 9 years of consulting experience in the Commercial and Market Access fields. The focus of Jacopo’s consulting activities is partnering with big pharma and clinical stage biotechs to help them develop and commercialize products across all therapeutic areas and geographies.

Dr. Vasee Moorthy is Senior Advisor, Research for Health Department, WHO Science Division, Geneva, Switzerland. Since 2008, he has held progressively senior roles at WHO in malaria vaccine policy development, Ebola vaccine phase 1-2 trials, global norms in sharing research data and results during public health emergencies, WHO R&D Blueprint for action to prevent epidemics, global consensus on clinical trials policy norms, WHO COVID-19 Research & Innovation Roadmap and the WHO Solidarity Trial of therapeutics supporting clinical trials networks in over 40 Member States in all WHO regions, and most recently, the adoption of resolution (WHA75.8) on clinical trials. Prior to joining WHO, Dr. Moorthy worked as a medical researcher at the University of Oxford, UK (2005-2008); with an NGO, PATH, in USA (2003-2005); running a clinical trials programme at MRC Laboratories in The Gambia (1999-2003), and as a government medical officer in Kwazulu/Natal, South Africa (1996-1997). He received a B.A. and M.A. from the University of Cambridge in Natural Sciences, a B.M.B.Ch medical degree and a Ph.D in malaria immunology and clinical trials both from the University of Oxford.

George is an experienced Senior Clinical Research Professional with a demonstrated history of working in the pharmaceutical industry from big pharma (Novartis, Pfizer) and medium sized biotech (Arena Pharmaceuticals) to Biotech startup (Granite Bio) and non-profit organizations (AO Foundation).
He is involved in all Clinical Operation activities and Sponsor-CRO relationships for more than 10 years and he gained a holistic experience in Vendor Oversight/Management activities for various vendors and Patient Recruitment initiatives.

Earlier in his career, George was acting as Research Scientist in Analytical Chemistry.

Graduated with a B.Sc. in Chemistry from the Aristotle University of Thessaloniki, acquired a M.Sc. in Pharmaceutical Engineering from KTH, The Royal Institute of Technology in Stockholm and holds an M.B.A. from the University of Sheffield, where he focused on healthcare and marketing.